BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8645861)

  • 1. [Ductal carcinoma in situ in dynamic MR-mammography at 1.5 T].
    Fischer U; Westerhof JP; Brinck U; Korabiowska M; Schauer A; Grabbe E
    Rofo; 1996 Apr; 164(4):290-4. PubMed ID: 8645861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphology and contrast enhancement of ductal carcinoma in situ in dynamic 1.0 T MR mammography].
    Sittek H; Kessler M; Heuck AF; Bredl T; Perlet C; Künzer I; Lebeau A; Untch M; Reiser M
    Rofo; 1997 Sep; 167(3):247-51. PubMed ID: 9376552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ductal carcinoma in situ: is there a role for MRI?
    Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of ductal carcinoma in situ in magnetic resonance imaging.
    Facius M; Renz DM; Neubauer H; Böttcher J; Gajda M; Camara O; Kaiser WA
    Clin Imaging; 2007; 31(6):394-400. PubMed ID: 17996602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced MR imaging of the breast in patients with breast implants after cancer surgery.
    Boné B; Aspelin P; Isberg B; Perbeck L; Veress B
    Acta Radiol; 1995 Mar; 36(2):111-6. PubMed ID: 7710787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gadolinium-DTPA (Magnevist) as contrast medium for galactography].
    Kaltenborn H; Schadmand S; Beck T; Thelen M
    Rofo; 1995 Nov; 163(5):457-9. PubMed ID: 8527765
    [No Abstract]   [Full Text] [Related]  

  • 7. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
    Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
    Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ductal carcinoma in situ of the breast: MR imaging findings with histopathologic correlation.
    Mossa-Basha M; Fundaro GM; Shah BA; Ali S; Pantelic MV
    Radiographics; 2010 Oct; 30(6):1673-87. PubMed ID: 21071382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?
    Hahn SY; Han BK; Ko EY; Shin JH; Hwang JY; Nam M
    Acta Radiol; 2013 Sep; 54(7):742-8. PubMed ID: 23588154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging.
    Viehweg P; Lampe D; Buchmann J; Heywang-Köbrunner SH
    MAGMA; 2000 Dec; 11(3):129-37. PubMed ID: 11154954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR imaging of ductal carcinoma in situ.
    Orel SG; Mendonca MH; Reynolds C; Schnall MD; Solin LJ; Sullivan DC
    Radiology; 1997 Feb; 202(2):413-20. PubMed ID: 9015067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ.
    Soderstrom CE; Harms SE; Copit DS; Evans WP; Savino DA; Krakos PA; Farrell RS; Flamig DP
    Radiology; 1996 Nov; 201(2):427-32. PubMed ID: 8888235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic characteristics of ductal carcinoma in situ (DCIS) in dynamic breast MRI using computer-assisted analysis.
    Vag T; Baltzer PA; Dietzel M; Benndorf M; Gajda M; Camara O; Kaiser WA
    Acta Radiol; 2010 Nov; 51(9):955-61. PubMed ID: 20942728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False-positive results in dynamic MR mammography. Causes, frequency, and methods to avoid.
    Kaiser WA
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):539-55. PubMed ID: 7489307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma.
    Schouten van der Velden AP; Boetes C; Bult P; Wobbes T
    Am J Surg; 2006 Aug; 192(2):172-8. PubMed ID: 16860625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.
    Stomper PC; Herman S; Klippenstein DL; Winston JS; Edge SB; Arredondo MA; Mazurchuk RV; Blumenson LE
    Radiology; 1995 Nov; 197(2):387-95. PubMed ID: 7480682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MR mammography in patients at risk].
    Kaiser WA; Mittelmeier O
    Rofo; 1992 Jun; 156(6):576-81. PubMed ID: 1617179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis.
    Buadu LD; Murakami J; Murayama S; Hashiguchi N; Sakai S; Masuda K; Toyoshima S; Kuroki S; Ohno S
    Radiology; 1996 Sep; 200(3):639-49. PubMed ID: 8756909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ductal carcinoma in situ: MR imaging-histopathologic correlation.
    Gilles R; Zafrani B; Guinebretière JM; Meunier M; Lucidarme O; Tardivon AA; Rochard F; Vanel D; Neuenschwander S; Arriagada R
    Radiology; 1995 Aug; 196(2):415-9. PubMed ID: 7617854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of magnetic resonance imaging and other modalities in ductal carcinoma in situ detection.
    Ikeda DM; Birdwell RL; Daniel BL
    Magn Reson Imaging Clin N Am; 2001 May; 9(2):345-56, vii. PubMed ID: 11493424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.